REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

ACRO Biomedical Co., Ltd. (亚果生医股份有限公司) (Taiwan, China)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: ACRO Biomedical Co., Ltd. Profile Updated: January 27, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

ACRO Biomedical Co. specializes in biomedicine and cosmetic conservation products. Their offerings include ACro Glamour protein biomedicine and ACRODERM Cosmetic Conservation Products.

Headquarters
2Nd Fl., No. 57, Luke 2Nd Rd., Lujhu Dist
Kaohsiung City; Kaohsiung City;

Contact Details: Purchase the ACRO Biomedical Co., Ltd. (亚果生医股份有限公司) report to view the information.

Website: http://www.acrobiomedical.com

Basic Information
Total Employees:
Purchase the ACRO Biomedical Co., Ltd. (亚果生医股份有限公司) report to view the information.
Outstanding Shares:
Purchase the ACRO Biomedical Co., Ltd. (亚果生医股份有限公司) report to view the information.
Financial Auditors:
Purchase the ACRO Biomedical Co., Ltd. (亚果生医股份有限公司) report to view the information.
Incorporation Date:
June 26, 2014
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Assistant Vice President
Ownership Details
Purchase this report to view the information.
5.83%
Purchase this report to view the information.
4.08%
Purchase this report to view the information.
3.46%
Purchase this report to view the information.
2.76%
Purchase this report to view the information.
2.19%
Subsidiaries
Arco Regenmed Private Limited (India)
100%
Cong Ty Tnhh Acro Regenmed (Hong Kong SAR, China)
100%
亞果生醫(香港)股份有限公司 (Hong Kong SAR, China)
100%
Company Performance
Financial values in the chart are available after ACRO Biomedical Co., Ltd. (亚果生医股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-36.73%▼
Total operating revenue
-34.33%▼
Operating Profit/Loss (EBIT)
-68.12%▼
EBITDA
-54.39%▼
Net Profit/Loss for the Period
-67.3%▼
Total Assets
-11.67%▼
Total Equity
-11.97%▼
Operating Profit Margin (ROS)
-224.35%▼
Net Profit Margin
-205.91%▼
Return on Equity (ROE)
-3.59%▼
Debt/Equity
-0.55%▼
Quick Ratio
-11.03%▼
Cash Ratio
-30.65%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo